Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19

Implications: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autor principal: Samet, Jonathan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953960/
https://www.ncbi.nlm.nih.gov/pubmed/33320258
http://dx.doi.org/10.1093/ntr/ntaa187
Descripción
Sumario:Implications: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infection and the course of COVID-19 is addressed.

Ejemplares similares